Hovedindeksen (OSEBX.OL)

Close: 934.91 (+4.52), Dec 1, 2020
Hold

Low risk

Automatic technical analysis. Medium term, Dec 1, 2020

Hovedindeksen is in a rising trend channel in the medium long term. This shows that investors over time have bought the index at higher prices and indicates good development for the market. The index is testing the resistance at points 946. This could give a negative reaction, but an upward breakthrough of points 946 means a positive signal. RSI is above 70 after a good price increase the past weeks. The index has strong positive momentum and further increase is indicated. However, particularly for big stocks, high RSI may be a sign that the stock is overbought and that there is a chance of a reaction downwards. The index is overall assessed as technically neutral for the medium long term.

Recommendation one to six months: Hold (Score: 3)

Period  
Vol.bal. Volatility Liquidity +/- %
1 day-0.99%5 793.45+0.49%
5 days-17.193.22%7 656.23-0.02%
22 days-7.239.05%6 590.62+15.16%
66 days2.8318.96%5 546.47+8.80%

More analyses of Hovedindeksen

chart Hovedindeksen (OSEBX) Candlesticks 22 Days
Candlesticks
chart Hovedindeksen (OSEBX) Short term
Short term: Positive
chart Hovedindeksen (OSEBX) Medium term
Medium term: Hold
chart Hovedindeksen (OSEBX) Long term
Long term: Hold
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK